Tore Jarl Gutteberg
University of Tromsø
68 Papers
336 Citations
Tore Jarl Gutteberg is an academic researcher from University of Tromsø. The author has contributed to research in topics: Medicine & Lactoferricin. The author has an hindex of 27, co-authored 67 publications. Previous affiliations of Tore Jarl Gutteberg include University Hospital of North Norway.
Chat about Author
Papers
Modulation of blood cell activation by four commonly used anticoagulants
TL;DR: The aim of this study was to compare the effect of the four anticoagulants EDTA, citrate, heparin and hirudin on monocyte, neutrophil (PMN), and platelet function in human whole blood and concluded that the antICOagulant used in in vitro experiments has a large influence on the parameters measured.
A wide range of medium-sized, highly cationic, α-helical peptides show antiviral activity against herpes simplex virus
TL;DR: The peptides were able to inhibit the entry of HSV-1 into the host cell, probably by blocking HS at the cell surface, and the plaque size was smaller compared to the untreated control, indicating that the peptides may also interfere with cell-to-cell spread of the virus.
HPV mRNA Is More Specific than HPV DNA in Triage of Women with Minor Cervical Lesions
Sveinung Wergeland Sørbye,Silje Fismen,Tore Jarl Gutteberg,Elin Synnøve Mortensen,Finn Egil Skjeldestad +4 more
TL;DR: In triage of repeated ASC-US/LSIL, HPV mRNA testing is more specific and is more relevant in clinical use than an HPV DNA test, and the higher positivity rate of the DNA test in triage leads to higher referral rate for colposcopy and biopsy, and subsequent additional follow-up of negative biopsy.
Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment : real-life experience from a multicenter study in Sweden and Norway
Midori Kjellin,Hege Kileng,Dario Akaberi,Navaneethan Palanisamy,Ann-Sofi Duberg,Astrid Danielsson,Magnhild Gangsøy Kristiansen,Johan Edvin Nöjd,Soo Aleman,Tore Jarl Gutteberg,Rasmus Goll,Anders Lannergård,Johan Lennerstrand +12 more
TL;DR: The results from this real-life study are in accordance with the findings of the randomised controlled trials in 2015 and the EASL-guidelines of 2016, thus, baseline Y93H impacts on DCV and VEL treatment outcome.
Prediction of Activity, Synthesis and Biological Testing of anti‐HSV Active Peptides
TL;DR: The use of principal properties of amino acids for developing quantitative structure–activity relationships (QSAR:s) as a tool for modelling peptide activity and predicting the activity of new peptides is reported on.